screening for viral hepatitis C in a young Tunisian population (more than 175,000 recruits)

##plugins.themes.academic_pro.article.sidebar##

Published Jan 18, 2016
Download
pdf
Vol. 93 No. 12 (2015): Issue Dec 2015

##plugins.themes.academic_pro.article.main##

Sondes Bizid
Sahar Ben Sassi
Hatem Ben Abdallah
Afifa Doghri
Chokri Tounsi
Riadh Bouali
Nasreddine Gritli
Nabil Abdelli
Mondher Yedeas
Ali Mrabet

Abstract

SUMMARY
Background: In front of the considerable impact of the viral hepatitis C, the prevention is more than ever a priority, based essentially on the screening.
Aim: We realized an epidemiological study in a population of young recruits with the aim of considering prevalence of anti-hepatitis C Virus (anti-HCV) antibodies, describing its epidemiological evolution and establishing a cartography of the viral hepatitis C in Tunisia.
Methods: Epidemiological retrospective study of prevalence was realized from the data of the screening of anti-HCV antibodies from 2003 till 2012 of all the young recruits suggested to be incorporated for the national service or suggested to be recruited as career soldier. The study was exhaustive concerning 175 322 young and healthy male adults aged between 20 and 30 years old, originating from all parts of Tunisia. The screening was realized by third and fourth generation ELISA tests then validated by Immunoblot.
Results: The prevalence was 0.11% and the confirmed prevalence was 0.07%. The positive subjects were mainly between 20 and 25 years old (82.32%) and 91.05% were detected within the framework of their incorporations to the national service. The lowest prevalence was 0.07% in 2004, and the highest was 0.17% in 2011, without a significant tendency in the increase or in the decrease during the period of study (r = 0.857 ; p = 0.564). The screening of anti-VHC antibodies had an unequal geographical distribution according to a North-South decreasing gradient. The highest proportions were registered in the North-West (23.23%) and the District of Tunis (22.73%), contrary to the South-East which was weakly affected (3.54%). The governorates with the highest proportions were Tunis (19.19%), Bizerte (11.62%) and Jendouba (8.59%), the governorates of Monastir and Tataouine were weakly affected (0.51%).

Conclusion: Prevalence of anti-HCV antibodies in the young and male Tunisian population was weak, stable without significant tendency in the increase or in the decrease from 2003 till 2012, characterized by an unequal geographical distribution according to a North-South decreasing gradient.

##plugins.themes.academic_pro.article.details##

References

  1. Société Tunisienne de Gastro-entérologie. Traitement des Hépatites Chroniques Virales B et C. Réunion Tunisienne de Consensus. Tunis: STGE; 2006.
  2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-67
  3. Institut National de la Statistique. Caractéristiques démographiques de la population [En ligne]. Institut National de la Statistique, 2013 [cité le 10/04/2014]. Disponible à l'URL: http://www.ins.nat.tn/indexfr.php.
  4. Lavanchy D. Evolving epidemiology of hepatitis C virus: Epidemiology of HCV. Clin Microbiol Infect. 2011;17:107-15.
  5. Debbech R, Said Y, Ben Temime H, El Jery K, Bouzaïdi S, Salem M, et al. Epidémiologie de l'hépatite C en Tunisie. Tunis Med. 2013;91:86-91.
  6. Bouali M, Said N, Khediri M. Prevalence of hepatitis B and C in more than 56.000 blood donors. J Hepatol. 1997;26 Supp 1:S172.
  7. Labidi B. Recherche des anticorps anti-VHC chez 90734 donneurs de sang [Thèse]. Médecine: Tunis; 1998.
  8. Gorgi Y, Yalaoui S, Ben Nejma HL, Azzouz MM, Hsairi M, Ben Khelifa H, et al. Detection of hepatitis C virus in the general population of Tunisia. Bull Soc Pathol Exot. 1998;91:177.
  9. Mejri S, Ben Salah A, Triki H, Ben Alaya N, Djebbi A, Dellagi K. Contrasting patterns of hepatitis C virus infection in two regions from Tunisia. J Med Virol. 2005;76:185-93.
  10. Ben Khélifa H, Gorgi Y, Sfar I, Hssairi M, Ayed K. Prévalence du portage chronique des virus B, D et C en Tunisie. Résultats d'une enquête Nationale. Xème Congrès National de la Société Tunisienne de Gastroentérologie. Livre des résumés 2006 ; p 30:A 23.
  11. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg. 1997;91:11-4.
  12. Halfon P, Ouzan D, Cattan L, Cacoub P. Les outils du diagnostic de l'infection par le virus de l'hépatite C. Presse Med. 2004;33:538-41.
  13. Zachary P, Ullmann M, Djeddi S, Wendling MJ, Schvoerer E, Stoll-Keller F, et al. Intérêt de l'immunoblot dans l'évaluation du statut sérologique vis-Ã -vis de l'hépatite C. Pathol Biol. 2004;52:517-21.
  14. Benjelloun S, Bennani A, Sekkat S, Ben Slimane A. Les hépatites virales au Maroc : aspects épidémiologique et moléculaire. Medecine et Armees. 2003;31:352-6.
  15. Sehonou J, Atadokpede F, Abdoulaye I, Kodjoh N, Zohoun I. Séroprévalence des anticorps antivirus de l'hépatite C dans une population de jeunes recrues au Bénin. J Afr Hepato-Gastroenterol. 2007;1:103-5.
  16. Hyams KC, Riddle J, Rubertone M, Trump D, Alter MJ, Cruess DF, et al. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21.000 troops. Am J Epidemiol. 2001;153:764-70.
  17. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, et al. 45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults. Ann Intern Med. 2000;132:105-11.
  18. Organisation Mondiale de la Santé. Hépatite C Aide-mémoire N°164 [En ligne]. Organisation Mondiale de la Santé, 2013 [cité le 04/02/2014]. Disponible à l'URL: http://www.who.int/mediacentre/factsheets/fs164/fr/
  19. World Health Organization. Guidelines for the sreening, care and treatment of persons with hepatitis C infection [En ligne]. World Health Organization, 2014 [cité le 30/04/2014]. Disponible à l'URL: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/